Asset Management One Co. Ltd. Increases Stock Position in CVS Health Corporation (NYSE:CVS)

Asset Management One Co. Ltd. lifted its position in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 7.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 514,355 shares of the pharmacy operator's stock after purchasing an additional 35,894 shares during the period. Asset Management One Co. Ltd.'s holdings in CVS Health were worth $34,848,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the company. McIlrath & Eck LLC lifted its position in shares of CVS Health by 32.6% during the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after purchasing an additional 174 shares in the last quarter. Coppell Advisory Solutions LLC lifted its position in shares of CVS Health by 17.3% during the fourth quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator's stock valued at $56,000 after purchasing an additional 189 shares in the last quarter. EagleClaw Capital Managment LLC lifted its position in shares of CVS Health by 3.4% during the fourth quarter. EagleClaw Capital Managment LLC now owns 6,135 shares of the pharmacy operator's stock valued at $275,000 after purchasing an additional 200 shares in the last quarter. Angeles Investment Advisors LLC lifted its position in shares of CVS Health by 3.7% during the fourth quarter. Angeles Investment Advisors LLC now owns 5,706 shares of the pharmacy operator's stock valued at $256,000 after purchasing an additional 204 shares in the last quarter. Finally, Beck Mack & Oliver LLC lifted its position in shares of CVS Health by 1.1% during the fourth quarter. Beck Mack & Oliver LLC now owns 20,425 shares of the pharmacy operator's stock valued at $917,000 after purchasing an additional 232 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Barclays set a $79.00 price objective on shares of CVS Health and gave the stock an "overweight" rating in a research report on Monday, June 2nd. Robert W. Baird lifted their price objective on shares of CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Wells Fargo & Company reaffirmed an "overweight" rating and issued a $84.00 price objective (up previously from $76.00) on shares of CVS Health in a research report on Tuesday, May 6th. Wall Street Zen raised shares of CVS Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Finally, Morgan Stanley reaffirmed an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. Two research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $74.75.

CVS Health Price Performance

Shares of CVS traded up $0.36 during mid-day trading on Friday, reaching $68.50. 5,937,044 shares of the stock traded hands, compared to its average volume of 10,854,461. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $72.51. The company has a market cap of $86.66 billion, a price-to-earnings ratio of 16.35, a price-to-earnings-growth ratio of 0.98 and a beta of 0.56. The firm has a fifty day moving average price of $64.86 and a 200 day moving average price of $60.86.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business had revenue of $94.59 billion during the quarter, compared to analysts' expectations of $93.07 billion. During the same quarter in the previous year, the company earned $1.31 EPS. The business's quarterly revenue was up 7.0% compared to the same quarter last year. As a group, equities research analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

Insider Buying and Selling at CVS Health

In other news, Director Guy P. Sansone purchased 1,570 shares of the company's stock in a transaction on Thursday, June 5th. The stock was acquired at an average price of $63.70 per share, with a total value of $100,009.00. Following the transaction, the director now directly owns 12,007 shares of the company's stock, valued at approximately $764,845.90. This represents a 15.04% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.22% of the stock is currently owned by corporate insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.